Cim, LLC Novo Nordisk A S Transaction History

Cim, LLC

$676 Million
Q2 2024

A detailed history of Cim, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cim, LLC holds 220,373 shares of NVO stock, worth $25 Million. This represents 4.65% of its overall portfolio holdings.

Number of Shares

220,373

Previous 222,285 0.86%

Holding current value

$25 Million

Previous $28.5 Million 10.21%

% of portfolio

4.65%

Previous 4.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 06, 2024	SELL	$122.71 - $146.91 $234,621 - $280,891	-1,912 Reduced 0.86%	220,373 $31.5 Million
Q1 2024 May 20, 2024	SELL	$102.11 - $135.92 $544,961 - $725,405	-5,337 Reduced 2.34%	222,285 $28.5 Million
Q4 2023 Feb 23, 2024	BUY	$87.78 - $105.45 $9.9 Million - $11.9 Million	112,823 Added 98.28%	227,622 $23.5 Million
Q3 2023 May 17, 2024	BUY	$90.94 - $199.54 $10.8 Million - $23.8 Million	119,138 Added 113.43%	224,168 $20.4 Million
Q2 2023 May 17, 2024	SELL	$155.98 - $172.65 $19.1 Million - $21.2 Million	-122,592 Reduced 53.86%	105,030 $17 Million
Q1 2023 May 17, 2024	SELL	$132.34 - $159.14 $15.9 Million - $19.1 Million	-120,023 Reduced 52.73%	107,599 $17.1 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $4.32 Million - $5.7 Million	-42,094 Reduced 26.83%	114,799 $15.5 Million
Q3 2022 Nov 02, 2022	SELL	$95.28 - $116.93 $769,100 - $943,858	-8,072 Reduced 4.89%	156,893 $16.7 Million
Q2 2022 Jul 11, 2022	SELL	$103.24 - $121.81 $731,042 - $862,536	-7,081 Reduced 4.12%	164,965 $18 Million
Q1 2022 Apr 12, 2022	SELL	$93.1 - $112.54 $2.97 Million - $3.59 Million	-31,866 Reduced 15.63%	172,046 $20.8 Million
Q4 2021 Jan 26, 2022	SELL	$95.88 - $117.08 $964,840 - $1.18 Million	-10,063 Reduced 4.7%	203,912 $19.4 Million
Q3 2021 Nov 08, 2021	SELL	$84.42 - $106.62 $477,563 - $603,149	-5,657 Reduced 2.58%	213,975 $24.3 Million
Q2 2021 Aug 09, 2021	BUY	$67.66 - $84.76 $61,299 - $76,792	906 Added 0.41%	219,632 $21.8 Million
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $259,321 - $293,195	-3,867 Reduced 1.74%	218,726 $16.7 Million
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $31,561 - $36,457	494 Added 0.22%	222,593 $15.9 Million
Q3 2020 Nov 06, 2020	BUY	$63.69 - $70.22 $239,283 - $263,816	3,757 Added 1.72%	222,099 $15.9 Million
Q2 2020 Aug 07, 2020	SELL	$58.54 - $67.94 $51,983 - $60,330	-888 Reduced 0.41%	218,342 $14.3 Million
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $180,281 - $236,123	-3,645 Reduced 1.64%	219,230 $13.2 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $1.16 Million - $1.36 Million	23,310 Added 11.68%	222,875 $12.9 Million
Q3 2019 Oct 15, 2019	BUY	$47.54 - $53.43 $165,249 - $185,722	3,476 Added 1.77%	199,565 $10.3 Million
Q2 2019 Jul 22, 2019	BUY	$46.79 - $52.47 $180,656 - $202,586	3,861 Added 2.01%	196,089 $10 Million
Q1 2019 May 06, 2019	BUY	$46.36 - $52.63 $109,455 - $124,259	2,361 Added 1.24%	192,228 $10.1 Million
Q4 2018 Jan 29, 2019	BUY	$41.54 - $47.25 $95,583 - $108,722	2,301 Added 1.23%	189,867 $8.75 Million
Q3 2018 Oct 29, 2018	SELL	$46.76 - $51.24 $709,863 - $777,874	-15,181 Reduced 7.49%	187,566 $8.84 Million
Q2 2018 Jul 10, 2018	BUY	$44.29 - $50.42 $97,526 - $111,024	2,202 Added 1.1%	202,747 $9.35 Million
Q1 2018 Apr 05, 2018	SELL	$48.49 - $58.14 $73,122 - $87,675	-1,508 Reduced 0.75%	200,545 $9.88 Million
Q4 2017 Jan 23, 2018	BUY	$47.53 - $53.73 $381,190 - $430,914	8,020 Added 4.13%	202,053 $10.8 Million
Q3 2017 Nov 03, 2017	SELL	$41.15 - $49.22 $22,179 - $26,529	-539 Reduced 0.28%	194,033 $9.34 Million
Q2 2017 Aug 09, 2017	BUY	N/A	194,572	194,572 $8.35 Million

Others Institutions Holding NVO

# of Institutions

1,963

Shares Held

320M

Call Options Held

5.16M

Put Options Held

4.96M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $256B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cim, LLC with notifications on news.

Account